Advances in triazole antimicrobial agents

Chinese Journal of Antibiotics

Volumn 32, Issue 10, 2007, Pages 587-593

  Mi, Jia Li ^a   Zhou, Cheng He ^a,b   Bai, Xue ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

Antibacterial; Antifungal; Antituberculotic; Antiviral; Triazole

Indexed keywords

1 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 3 [4 (1H TETRAZOL 1 YL)PHENYL] 2 IMIDAZOLIDINONE; 2 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 4 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL] 1,2,4 TRIAZOL 3(2H) ONE; 4 [4 [4 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 1 PIPERAZINYL]PHENYL] 2,4 DIHYDRO 2 [4 (TRIFLUOROMETHOXY)BENZYL] 1,2,4 TRIAZOL 3 ONE; 4 [4 [5 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4, TRIAZOL 1 YL)PROPYLTHIO] 1,3 DIOXAN 2 YL] 1,3 BUTADIENYL] 3 FLUOROBENZONITIRLE; ALBACONAZOLE; ALPHA (4 CHLOROPHENYL) ALPHA (1 CYCLOPROPYL 1 METHYLETHYL) 1H 1,2,4 TRIAZOLE 1 ETHANOL; ANTIINFECTIVE AGENT; AZOLINE; ELECTRAZOLE; GENACONAZOLE; KP 103; POSACONAZOLE; SCH 50001; SCH 50002; SCH 51048; SCH 59884; T 8581; TRIAZOLE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; DRUG MECHANISM; PHARMACOPHORE; REVIEW;

EID: 37049002838     PISSN: 10018689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Boucher H W, Groll A H, Chiou C C, et al. Newer systemic antifungal agents pharmacokinetics, safety and efficacy [J]. Drugs, 2004,64(18):1997-2020.
2. Chinese source
3. Chinese source
4. Bennett F, Saksena A K, Lovey RG, et al. Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S,S)-5] [J]. Bioorg Med Chem Lett, 2006, 16(1):186-190.
5. Parang K, Sardari S. Azole derivatives and methods for making the same: WO2005/006860 A2 [P]. 2005-01-27
6. Bentley A, Butters M, Green S P, et al. The discovery and process development of a commercial route to the water soluble prodrug, Fosfluconazole [J]. Org Proc Res Dev, 2002,6(2):109-112.
7. Zhou C H, Bai X, Li T Q, et al. Synthesis and antifungal activity of novel soluble gluco-fluconazole triazolium [J]. Chin J Org Chem, 2005,25(Suppl):574.
8. Corrales M, Cardozo R, Segura M A, et al. Comparative efficacies of tAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of chagas' disease [J]. Antimicrob Agents Chemother, 2005,49(4):1556-1560.
9. Capilla J, Yustes C, Mayayo E, et al. Efficacy of albaconazole (UR-9825) in treatment of disseminated scedosporium prolificans infection in rabbits [J]. Antimicrob Agents Chemother, 2003,47(6):1948-1951.
10. Roberts J, Schock K, Marino S, et al. Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis [J]. Antimicrob Agents Chemother, 2000,44(12):3381-3388.
11. Kamai Y, Harasaki T, Fukuoka T, et al. In vitro and in vivo activities of CS-758 (R-120758), a new triazole antifungal agent [J]. Antimicrob Agents Chemother, 2002,46 (2):367-370.
12. Matysiak J, Niewiadomy A. Synthesis and antimycotic activity of N-azolyl-2,4-dihydroxythiobenzamides [J]. Bioorg Med Chem, 2003,11(10):2285-2291.
13. Collin X, Sauleau A, Coulon J. 1.2,4-Triazolo mercapto and aminonitriles as potent antifungal agents [J]. Bioorg Med Chem Lett, 2003,13(15):2601-2605.
14. Emami S, Falahati M, Banifatemi A, et al. (E)- and (Z)-1,2,4-Triazolylchromanone oxime ethers as conformationally constrained antifungals [J]. Bioorg Med Chem, 2004,12(15):3971-3976.
15. Chinese source
16. Romero A, Chang-Hsing L, Yu-Hung C, et al. An efficient entry to new sugar modified ketolide antibiotics [J]. Tetrahedron Lett, 2005,46(9):1483-1487.
17. Phillips O A, Udo E E, Ali A A M, et al. Synthesis and antibacterial activity of 5-substttuted oxazolidinones [J]. Bioorg Med Chem, 2003,11(1):35-41.
18. Demirayak S, Benkli K, Guuven K. Synthesis and antimicrobial activities of some 3-arylamino-5-[2-(substituted1-imidazolyl)ethyl]-1,2,4-triazole derivatives [J]. Eur J Med Chem, 2000,35(11):1037-1040.
19. Turan-Zitouni G, Kaplakcikli Z A, Yildiz M T, et al. Synthesis and antimicrobial activity of 4-phenyl/cyclohexyl-5-(1-phenoxyethyl)-3-[N-(2- thiazolyl)acetamido] thio-4H-1,2,4- triazole derivatives [J]. Eur J Med Chem, 2005,40(6):607-613.
20. Yang J G, Pan F Y, Shao H. Synthesis, crystal structure and antibacterial activities of 3-[3-methyl-(2-thienyl)methylenehydrazinocarbonyl]-(1H)-1,2,4- triazol [J]. Chin J Struct Chem, 2005,11(24):1286-1289.
21. Kidwai M, Dave B, Misra P, et al. Novel synthetic approach for antifungal and antibacterial organotin compounds [J]. Inorg Chem Commun, 2000,3(9):465-468.
22. Zahajská L, Klimesová V, Koci J, et al. Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1,2,4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile [J]. Arch Pharm, 2004,337(10):549-555.
23. Rodriguez-Fernández E, Manzano J L, Benito J J, et al. Thiourea, triazole and thiadiazine compounds and their metal complexes as antifungal agents [J]. J Inorg Biochem, 2005,99(8):1558-1572.
24. Foks H, Trapkowska I, Janowiec M, et al. Studies on pyrazine derivatives. 38. Synthesis, reactions, and tuberculostatic activity of pyrazinyl-substituted derivatives of hydrazinocarbodithioic acid [J]. Chem Heterocycl Compd, 2004,40(9):1185-1194.
25. Borowski P, Lang M, Niebuhr A, et al. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3- carboxamide-5′-triphosphate (ribavirin-TP) [J]. Acta Biochim Pol, 2001,48 (3):739-744.
26. Cho J H, Bernard D L, Sidwell R W, et al. Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS [J]. J Med Chem, 2006,49(3):1140-1148.
27. Gunaga P, Moon H R, Choi WJ, et al. Recent advances in 4′-thionucleosides as potential antiviral and antitumor agents [J]. Curr Med Chem, 2004,11(10):2585-2637.
28. Bretner M, Baier A, Kopanska K, et al. Synthesis and biological activity of 1H-benzotriazole and 1H-benzimidazole analogues - inhibitors of the NTpase/helicase of HCV and of some related Flaviviridae [J]. Antiviral Chem Chemother, 2005,16(5):315-326.
29. Price D A, Gayton S, Selby M D, et al. Initial synthesis of UK-427, 857 (Maraviroc) [J]. Tetrahedron Lett, 2005,46(30):5005-5007.
30. Long Y Q, Jiang X H, Dayam R, et al. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase : implication for binding to two metal ions on the active site of integrase [J]. J Med Chem, 2004,47(10):2561-2573.